Residual blood

OTHER2 trials

Sponsors

Yonsei University, Gachon University Gil Medical Center

Conditions

Cardiac DysfunctionExtracorporeal Membrane OxygenationPharmacokinetics

Unknown Phase

Population Pharmacokinetics of Teicoplanin, Levofloxacin, Piperacillin/Tazobactam, Meropenem, Vancomycin, Remifentanil, Cefepime, Cefpirome, Sufentanil, Midazolam, Clopidogrel, Ticagrelor, Prasugrel During Veno-arterial Extracorporeal Membrane Oxygenation (VA ECMO)

CompletedNCT02581280

Yonsei UniversityCardiac Dysfunction

Start: 2014-12-31End: 2019-01-31Updated: 2019-11-13

Population PK of Antibiotics, Sedative and Analgesics, and Antiplatelet Drugs During ECMO

Gachon University Gil Medical CenterExtracorporeal Membrane Oxygenation, Pharmacokinetics

Start: 2019-07-16End: 2024-07-15Target: 10Updated: 2022-06-27

Related Papers

Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.

2021-12-2213 citations

Dose Optimization of Cefpirome Based on Population Pharmacokinetics and Target Attainment during Extracorporeal Membrane Oxygenation.

2020-04-216 citations

Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy

Critical Care2019-07-0910 citations

Population Pharmacokinetics and Dose Optimization of Teicoplanin during Venoarterial Extracorporeal Membrane Oxygenation

Antimicrobial Agents and Chemotherapy2017-07-0427 citations